EPISODE · Apr 24, 2014 · 9 MIN
The Lancet: April 24, 2014
from Listen to The Lancet · host The Lancet
Marcia Brose discusses results of a phase III trial of the kinase inhibitor sorafenib for treating radioactive iodine-refractory thyroid cancer.
Embed this episode
NOW PLAYING
The Lancet: April 24, 2014
0:00
9:23
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Listen to The Lancet?
This episode is 9 minutes long.
When was this Listen to The Lancet episode published?
This episode was published on April 24, 2014.
Can I download this Listen to The Lancet episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!